Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

A JOINT FRAMEWORK FOR 4D SEGMENTATION AND ESTIMATION OF SMOOTH TEMPORAL APPEARANCE CHANGES.
DRUG DELIVERY TO CNS: CHALLENGES AND OPPORTUNITIES WITH EMPHASIS ON BIOMATERIALS BASED DRUG DELIVERY STRATEGIES.
Microglia play a major role in direct viral-induced demyelination.
Validity of visual perceptive computing for static posturography in patients with multiple sclerosis.
MAPT gene rs1052553 variant is not associated with the risk for multiple sclerosis.
Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis.
Endocannabinoid signalling and the deteriorating brain.
The neurotrophic hepatocyte growth factor induces protolerogenic human dendritic cells.
Differential effects of genetic susceptibility factors in males and females with multiple sclerosis.
Neurological disorders and celiac disease.
Acute toxic neuropathy mimicking guillain barre syndrome.
Development of an Aquaporin-4 Orthogonal Array of Particle-Based ELISA for Neuromyelitis Optica Autoantibodies Detection.
[Effects of caffeine citrate on myelin basic protein in neonatal rats with hypoxic-ischemic brain damage].
The US Network of Pediatric Multiple Sclerosis Centers: Development, Progress, and Next Steps.
Immunopathological characteristics of patients with bullous pemphigoid and neurological disease.
Obesity diminishes synaptic markers, alters microglial morphology, and impairs cognitive function.
Noise robust spatially regularized myelin water fraction mapping with the intrinsic B1 -error correction based on the linearized version of the extended phase graph model.
Patient satisfaction with the BETACONNECT™ autoinjector for interferon beta-1b.
Ventricular arrhythmia in a male MS patient on fingolimod.
Improving drug delivery technology for treating neurodegenerative diseases.
Acquired demyelinating disorders of central nervous system: A pediatric cohort.
Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.
[New therapeutic options in multiple sclerosis].
Do coping styles mediate the relationship between disability status and psychosocial loss in people with relapsing remitting multiple sclerosis?
Psychosocial difficulties from the perspective of persons with neuropsychiatric disorders.

Pages